Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
05 2021
Historique:
revised: 27 07 2020
received: 28 05 2020
accepted: 11 08 2020
pubmed: 9 10 2020
medline: 30 9 2021
entrez: 8 10 2020
Statut: ppublish

Résumé

Ecological studies have suggested that Cannabis legalization might have led to a decrease in opioid overdose deaths. Such studies do not provide information about whether individuals are substituting Cannabis for opioids at different points in time. The current study assessed the magnitude of the daily association between Cannabis and opioid use in individual adults with and without pain who use non-medical opioids. Prospective cohort study. The greater New York area and a suburban inpatient addiction program. Adults with problem substance use who use non-medical opioids, recruited from May 2016-June 2019. The analytical sample included 13 271 days of observation among 211 participants (64% male, 41% white, 78% unmarried, 80% unemployed, mean age 43 years). Participants completed interviewer- and self-administered computerized surveys, and then responded to an interactive voice response (IVR) system daily for the following 90 days. The main exposures, Cannabis use and pain, were defined as responding affirmatively to the IVR question: 'Did you use Cannabis yesterday?' and endorsing moderate or severe pain at baseline, respectively. The main outcome, non-medical or illicit opioid use during 90-day follow-up, was defined as responding affirmatively to IVR question: 'Did you use heroin yesterday?' or 'Did you use prescription opioids more than prescribed or without a prescription yesterday?'. The mean IVR completion rate was 70%. The unadjusted odds ratio (aOR) indicating same-day use of Cannabis and opioids was 2.00 [95% confidence interval (CI) = 1.54-2.59]. Controlling for demographic characteristics, recruitment method, opioid types at baseline and pain, the aOR was 1.86 (95% CI = 1.44-2.41). A test of interaction between pain and Cannabis use to determine if the association of Cannabis with opioid use differed between people with moderate-to-severe pain and less-than-moderate pain was inconclusive. Among US adults with problem substance use who use non-medical opioids, the odds of opioid use appear to be approximately doubled on days when Cannabis is used. This relationship does not appear to differ between people with moderate or more severe pain versus less than moderate pain, suggesting that Cannabis is not being used as a substitute for illegal opioids.

Sections du résumé

BACKGROUND AND AIMS
Ecological studies have suggested that Cannabis legalization might have led to a decrease in opioid overdose deaths. Such studies do not provide information about whether individuals are substituting Cannabis for opioids at different points in time. The current study assessed the magnitude of the daily association between Cannabis and opioid use in individual adults with and without pain who use non-medical opioids.
DESIGN
Prospective cohort study.
SETTING
The greater New York area and a suburban inpatient addiction program.
PARTICIPANTS
Adults with problem substance use who use non-medical opioids, recruited from May 2016-June 2019. The analytical sample included 13 271 days of observation among 211 participants (64% male, 41% white, 78% unmarried, 80% unemployed, mean age 43 years).
MEASUREMENTS
Participants completed interviewer- and self-administered computerized surveys, and then responded to an interactive voice response (IVR) system daily for the following 90 days. The main exposures, Cannabis use and pain, were defined as responding affirmatively to the IVR question: 'Did you use Cannabis yesterday?' and endorsing moderate or severe pain at baseline, respectively. The main outcome, non-medical or illicit opioid use during 90-day follow-up, was defined as responding affirmatively to IVR question: 'Did you use heroin yesterday?' or 'Did you use prescription opioids more than prescribed or without a prescription yesterday?'.
FINDINGS
The mean IVR completion rate was 70%. The unadjusted odds ratio (aOR) indicating same-day use of Cannabis and opioids was 2.00 [95% confidence interval (CI) = 1.54-2.59]. Controlling for demographic characteristics, recruitment method, opioid types at baseline and pain, the aOR was 1.86 (95% CI = 1.44-2.41). A test of interaction between pain and Cannabis use to determine if the association of Cannabis with opioid use differed between people with moderate-to-severe pain and less-than-moderate pain was inconclusive.
CONCLUSIONS
Among US adults with problem substance use who use non-medical opioids, the odds of opioid use appear to be approximately doubled on days when Cannabis is used. This relationship does not appear to differ between people with moderate or more severe pain versus less than moderate pain, suggesting that Cannabis is not being used as a substitute for illegal opioids.

Identifiants

pubmed: 33029914
doi: 10.1111/add.15228
pmc: PMC8026758
mid: NIHMS1642173
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1113-1121

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA018652
Pays : United States

Informations de copyright

© 2020 Society for the Study of Addiction.

Références

Am J Psychiatry. 2018 Jan 1;175(1):47-53
pubmed: 28946762
JAMA Intern Med. 2014 Oct;174(10):1668-73
pubmed: 25154332
Med Care. 2000 Nov;38(11):1141-50
pubmed: 11078054
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
J Addict Med. 2018 Jul/Aug;12(4):259-261
pubmed: 29664894
Psychol Addict Behav. 2018 Dec;32(8):956-960
pubmed: 30359047
Addiction. 2018 Nov;113(11):2060-2070
pubmed: 29989239
Soc Sci Med. 2019 Jul;233:181-192
pubmed: 31207470
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Health Aff (Millwood). 2019 Sep;38(9):1550-1556
pubmed: 31479368
Drug Alcohol Depend. 2013 Oct 1;132(3):654-9
pubmed: 23683791
JAMA Intern Med. 2019 Jun 1;179(6):805-811
pubmed: 31058922
PLoS Med. 2019 Nov 19;16(11):e1002967
pubmed: 31743343
J Stud Alcohol. 1995 Sep;56(5):487-90
pubmed: 7475027
PLoS One. 2019 Oct 4;14(10):e0222577
pubmed: 31584957
Health Aff (Millwood). 2018 Jun;37(6):964-974
pubmed: 29863921
Drug Alcohol Depend. 2017 Apr 01;173:144-150
pubmed: 28259087
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
JAMA Intern Med. 2015 Apr;175(4):655-6
pubmed: 25844747
J Subst Abuse Treat. 2017 Dec;83:15-26
pubmed: 29129192
Am J Public Health. 2017 Nov;107(11):1827-1829
pubmed: 29019782
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12624-12626
pubmed: 31182592
JAMA Netw Open. 2019 Jul 3;2(7):e197216
pubmed: 31314118
PLoS One. 2020 Jan 17;15(1):e0227966
pubmed: 31951640
Health Aff (Millwood). 2016 Jul 1;35(7):1230-6
pubmed: 27385238
Drug Alcohol Depend. 2018 Jul 1;188:370-376
pubmed: 29776688
Prev Med. 2019 Sep;126:105736
pubmed: 31152831
Int J Epidemiol. 2001 Dec;30(6):1343-50
pubmed: 11821344
J Psychoactive Drugs. 2012 Apr-Jun;44(2):125-33
pubmed: 22880540
Am J Addict. 2015 Oct;24(7):599-606
pubmed: 26337603
Rehabil Psychol. 2005 Nov;50(4):381-388
pubmed: 26339107
J Health Econ. 2018 Mar;58:29-42
pubmed: 29408153
Pain. 2002 Dec;100(3):231-242
pubmed: 12467994
J Adolesc Health. 2013 Feb;52(2):158-63
pubmed: 23332479
Lancet Public Health. 2018 Jul;3(7):e341-e350
pubmed: 29976328
JAMA Intern Med. 2018 May 1;178(5):679-680
pubmed: 29610836
JAMA. 2015 Jun 23-30;313(24):2456-73
pubmed: 26103030
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):160-166
pubmed: 28861516
Health Aff (Millwood). 2019 Jan;38(1):14-23
pubmed: 30615514
Ann Intern Med. 2017 Sep 05;167(5):319-331
pubmed: 28806817
Behav Res Methods Instrum Comput. 2002 Aug;34(3):342-53
pubmed: 12395550
Int J Drug Policy. 2017 Apr;42:30-35
pubmed: 28189912
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
Am J Public Health. 2018 May;108(5):642-648
pubmed: 29565661
Pain. 2018 Oct;159(10):1932-1954
pubmed: 29847469
Health Aff (Millwood). 2017 May 1;36(5):945-951
pubmed: 28424215
Health Aff (Millwood). 2019 Feb;38(2):295-302
pubmed: 30715980
JAMA Intern Med. 2018 May 1;178(5):673-679
pubmed: 29610827
Addict Sci Clin Pract. 2014 Feb 17;9:5
pubmed: 24533631
Pain Med. 2020 Nov 1;21(11):3172-3179
pubmed: 32232476
J Addict Med. 2018 Jul/Aug;12(4):295-299
pubmed: 29664895
Drug Alcohol Depend. 2015 Feb 1;147:144-50
pubmed: 25533893
Am J Psychiatry. 2020 Jul 1;177(7):611-618
pubmed: 31964162

Auteurs

Lauren R Gorfinkel (LR)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.

Malki Stohl (M)

New York State Psychiatric Institute, New York, NY, USA.

Eliana Greenstein (E)

New York State Psychiatric Institute, New York, NY, USA.

Efrat Aharonovich (E)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Mark Olfson (M)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Deborah Hasin (D)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH